Abstract
SINCE the discovery by Laki and Lorand1 of a plasma factor responsible for rendering a fibrin clot insoluble in 5-M urea and in 1 per cent monochloracetic acid in the presence of ionized calcium, the importance of Laki-Lorand factor,2 also called fibrinase3 or fibrin-stabilizing factor (F.S.F.),4 has been recognized in the physiology of blood coagulation. The first researchers in this field concentrated on the identification,2 purification,5 , 6 measure of activity7 and mechanism of action of this factor,8 but at that time, its clinical implications were still unknown. Since 1960, when Duckert et al.9 first observed a familial hemorrhagic disorder by congenital . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
